![Jonathan P. Serbin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan P. Serbin
Nessuna posizione attualmente
Profilo
Jonathan P.
Serbin served as the Chief Executive Officer at d Mobile, Inc. from 2007 to 2010, and as the Director at Geos Communications, Inc. from 2010 to 2011.
He was also the Chief Financial Officer at Talon Therapeutics, Inc. in 2004 and at EBT Mobile Ltd.
from 2004 to 2007.
Additionally, he served as an Independent Director at Lihua International, Inc. from 2011 to 2014.
Serbin holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from the University of Washington, and a graduate degree from Boston University.
Precedenti posizioni note di Jonathan P. Serbin
Società | Posizione | Fine |
---|---|---|
LIHUA INTERNATIONAL, INC. | Direttore/Membro del Consiglio | 23/09/2014 |
GEOS COMMUNICATIONS INC | Direttore/Membro del Consiglio | 24/01/2011 |
d Mobile, Inc.
![]() d Mobile, Inc. Internet Software/ServicesTechnology Services Part of Geos Communications, Inc., d Mobile, Inc. is an investment holding American company that is involved in providing mobile value-added services. d Mobile was acquired by Geos Communications, Inc. on March 01, 2010 for $0.20 million. | Amministratore Delegato | 01/01/2010 |
EBT Mobile Ltd.
![]() EBT Mobile Ltd. Wireless TelecommunicationsCommunications EBT Mobile Ltd. specializes in mobile phone retail and services. EBT Mobile was acquired by The Trading Exchange Plc from EBT Mobile China Ltd. on September 21, 2005 for $35.75 million. | Direttore Finanziario/CFO | 01/12/2007 |
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Direttore Finanziario/CFO | - |
Formazione di Jonathan P. Serbin
The Trustees of Columbia University in The City of New York | Masters Business Admin |
University of Washington | Undergraduate Degree |
Boston University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Geos Communications, Inc.
![]() Geos Communications, Inc. Specialty TelecommunicationsCommunications Geos Communications, Inc. operates as a digital content distribution firm. It creates solutions for the rapidly growing global, mobile community, leveraging a unique combination. The firm provides products and applications that support the mobility of enterprises, small-to-medium businesses, and consumers. It also provides international and domestic long distance calling services to subscribers at a fraction of the cost of traditional carriers by leveraging the power of the Internet. The company was founded in 1988 and is headquartered in Southlake, TX. | Communications |
Lihua International, Inc.
![]() Lihua International, Inc. Electrical ProductsProducer Manufacturing Lihua International, Inc. engaged in the development, design, manufacture, production, and sale of copper replacement cable and wire products. Its products include copper anode, copper clad aluminum (CCA) cable and wire, and copper rod. The company was founded by Ya Ying Wang and Jian Hua Zhu on January 24, 2006 and was headquartered in Danyang, China. | Producer Manufacturing |
Talon Therapeutics, Inc.
![]() Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
EBT Mobile Ltd.
![]() EBT Mobile Ltd. Wireless TelecommunicationsCommunications EBT Mobile Ltd. specializes in mobile phone retail and services. EBT Mobile was acquired by The Trading Exchange Plc from EBT Mobile China Ltd. on September 21, 2005 for $35.75 million. | Communications |
d Mobile, Inc.
![]() d Mobile, Inc. Internet Software/ServicesTechnology Services Part of Geos Communications, Inc., d Mobile, Inc. is an investment holding American company that is involved in providing mobile value-added services. d Mobile was acquired by Geos Communications, Inc. on March 01, 2010 for $0.20 million. | Technology Services |
- Borsa valori
- Insiders
- Jonathan P. Serbin